CHIMERIX INC. - COMMO
0.9351
07-November-24 14:59:42
15 minutes delayed
Stocks
-0.0749
-7.42%
Today's range
0.9079 - 1.0500
ISIN
N/A
Source
NASDAQ
-
Chimerix Appoints Marc D. Kozin to Board of Directors
21 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
29 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
27 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
22 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Appoints Lisa Decker to Board of Directors
29 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
04 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
16 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
02 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
26 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
03 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
27 Jul 2023 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
27 Jun 2023 15:05:00 By Nasdaq GlobeNewswire
-
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
31 May 2023 15:01:00 By Nasdaq GlobeNewswire
-
25 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
04 May 2023 06:00:01 By Nasdaq GlobeNewswire
-
27 Apr 2023 06:00:01 By Nasdaq GlobeNewswire
-
18 Apr 2023 15:01:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
02 Mar 2023 06:00:01 By Nasdaq GlobeNewswire